4/27/2012

A study in Ophthalmology revealed more patients with diabetic macular edema who took ranibizumab attained better visual acuity and showed vision improvements than those who had sham treatments. Researchers also noted fewer cases of vision loss in the ranibizumab group compared with the sham treatment group.

Related Summaries